Menu
GeneBe

MSR1

macrophage scavenger receptor 1, the group of CD molecules|Scavenger receptor cysteine rich domain containing|Scavenger receptors

Basic information

Region (hg38): 8:16107877-16567490

Links

ENSG00000038945OMIM:153622HGNC:7376Uniprot:P21757AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Barrett esophagus (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Barrett esophagus/esophageal adenocarcinoma; Prostate cancerADGastrointestinal; OncologicAwareness of disease risk may allow surveillance, preventive measures (eg, related to Barrett esophagus) and early treatment of malignancy, which may reduce morbidity and mortalityGastrointestinal; Oncologic11443539; 12244320; 12839931; 12958598; 15536476; 16287155; 17768178; 17903305; 18398045; 20086112; 21791690
While some (eg, common) variants may increase the risk of prostate cancer slightly, others appear to confer much higher risk

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MSR1 gene.

  • Inborn genetic diseases (29 variants)
  • not provided (15 variants)
  • Ovarian cancer (8 variants)
  • Malignant tumor of prostate (2 variants)
  • Barrett esophagus (2 variants)
  • X-linked Alport syndrome (1 variants)
  • Hereditary cancer-predisposing syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MSR1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
4
clinvar
5
missense
5
clinvar
29
clinvar
2
clinvar
4
clinvar
40
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
1
clinvar
3
splice region
1
1
2
non coding
2
clinvar
1
clinvar
3
Total 1 6 29 6 9

Highest pathogenic variant AF is 0.0000526

Variants in MSR1

This is a list of pathogenic ClinVar variants found in the MSR1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-16110107-G-C not specified Uncertain significance (Jul 12, 2023)2599786
8-16110129-C-G not specified Uncertain significance (Nov 30, 2022)2330054
8-16110147-G-A not specified Uncertain significance (Sep 20, 2023)3212099
8-16110218-C-G Ovarian cancer Likely pathogenic (Jan 01, 2022)2445377
8-16120421-G-C not specified Uncertain significance (May 05, 2023)2544768
8-16120435-G-A not specified Uncertain significance (Dec 27, 2022)2226249
8-16120446-G-A Benign (Jul 14, 2017)712059
8-16120484-C-T not specified Uncertain significance (Dec 05, 2022)2332402
8-16120489-C-A not specified Uncertain significance (Oct 26, 2022)2320636
8-16120512-G-A Benign (Feb 26, 2018)782031
8-16120516-C-T not specified Uncertain significance (Feb 16, 2023)2486364
8-16120554-C-T MSR1-related disorder Benign (Nov 26, 2019)3060145
8-16120558-C-G not specified Uncertain significance (Nov 21, 2022)2223112
8-16120602-T-C MSR1-related disorder Benign (Jul 10, 2019)778941
8-16120614-G-T Likely benign (Dec 31, 2019)746739
8-16120615-TTAAAAA-T Likely benign (Dec 31, 2019)782854
8-16120615-TTAAAAAAA-T MSR1-related disorder Benign (Oct 31, 2019)3042130
8-16120615-TTAAAAAAAAA-T Likely benign (May 05, 2021)2075747
8-16120616-TA-T Benign (Jan 12, 2024)2776135
8-16143548-A-G Benign (Feb 26, 2018)714374
8-16143557-C-G Pathogenic (Jun 27, 2017)502674
8-16143577-C-T Benign (Aug 15, 2018)714511
8-16150284-C-T not specified Uncertain significance (Jul 17, 2023)2612317
8-16150291-C-A Uncertain significance (-)1049297
8-16150297-T-C not specified Uncertain significance (Aug 11, 2022)2306458

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MSR1protein_codingprotein_codingENST00000262101 9459613
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.16e-200.00024812563201161257480.000461
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-2.073412491.370.00001342955
Missense in Polyphen9975.6141.3093944
Synonymous-1.4310587.91.190.00000497838
Loss of Function-1.052721.71.240.00000105254

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.003080.00308
Ashkenazi Jewish0.000.00
East Asian0.0002180.000217
Finnish0.00009420.0000924
European (Non-Finnish)0.0002830.000281
Middle Eastern0.0002180.000217
South Asian0.0001000.0000980
Other0.0009840.000978

dbNSFP

Source: dbNSFP

Function
FUNCTION: Membrane glycoproteins implicated in the pathologic deposition of cholesterol in arterial walls during atherogenesis. Two types of receptor subunits exist. These receptors mediate the endocytosis of a diverse group of macromolecules, including modified low density lipoproteins (LDL) (PubMed:2251254). Isoform III does not internalize acetylated LDL (PubMed:9548586). {ECO:0000269|PubMed:2251254, ECO:0000269|PubMed:9548586}.;
Disease
DISEASE: Barrett esophagus (BE) [MIM:614266]: A condition characterized by a metaplastic change in which normal esophageal squamous epithelium is replaced by a columnar and intestinal-type epithelium. Patients with Barrett esophagus have an increased risk of esophageal adenocarcinoma. The main cause of Barrett esophagus is gastroesophageal reflux. The retrograde movement of acid and bile salts from the stomach into the esophagus causes prolonged injury to the esophageal epithelium and induces chronic esophagitis, which in turn is believed to trigger the pathologic changes. {ECO:0000269|PubMed:21791690}. Note=The disease may be caused by mutations affecting the gene represented in this entry. Genetic variants in MSR1 have been found in individuals with Barrett esophagus and are thought to contribute to disease susceptibility.;
Pathway
Phagosome - Homo sapiens (human);AGE-RAGE pathway;Vesicle-mediated transport;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors (Consensus)

Recessive Scores

pRec
0.0964

Intolerance Scores

loftool
0.106
rvis_EVS
0
rvis_percentile_EVS
54.03

Haploinsufficiency Scores

pHI
0.586
hipred
N
hipred_score
0.146
ghis
0.446

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.778

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Msr1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;

Gene ontology

Biological process
receptor-mediated endocytosis;phagocytosis, engulfment;negative regulation of gene expression;positive regulation of macrophage derived foam cell differentiation;positive regulation of cholesterol storage;cholesterol transport;plasma lipoprotein particle clearance;lipoprotein transport;amyloid-beta clearance
Cellular component
collagen trimer;plasma membrane;integral component of plasma membrane;integral component of membrane;endocytic vesicle membrane;low-density lipoprotein particle
Molecular function
amyloid-beta binding;scavenger receptor activity;protein binding;low-density lipoprotein particle binding